Skip to main content

REGULACION DE LA RECOMBINACION EN EL CONTEXTO CELULAR

SAF2016-74855-P

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D (Excelencia / Generación de Conocimiento)
Call year 2016
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSIDAD DE SEVILLA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Importance of hydrophobic interactions in the single-chained cationic surfactant-DNA complexation

  • López-López, Manuel
  • Checa-Rodríguez, Cintia
  • Prados-Carvajal, Rosario
  • Huertas Sánchez, Pablo
  • Moyá, María Luisa
López-López, Manuel et al., The goal of this work was to understand the key factors determining the DNA compacting capacity of single-chained cationic surfactants. Fluorescence, zeta potential, circular dichroism, gel electrophoresis and AFM measurements were carried out in order to study the condensation of the nucleic acid resulting from the formation of the surfactant-DNA complexes. The apparent equilibrium binding constant of the surfactants to the nucleic acid, K, estimated from the experimental results obtained in the ethidium bromide competitive binding experiments, can be considered directly related to the ability of a given surfactant as a DNA compacting agent. The plot of ln(K) vs. ln(cmc), cmc being the critical micelle concentration, for all the bromide and chloride surfactants studied, was found to be a reasonably good linear correlation. This result shows that hydrophobic interactions mainly control the surfactant DNA compaction efficiency., This work was financed by the Consejería de Innovación, Ciencia y Empresa de la Junta de Andalucía (P12-FQM-1105), FQM-274 and FQM-206, University of Seville (2017/1004), R+D+i grant from the Spanish Ministry of Economy and Competitivity (SAF2013-43255 and SAF2016-74855) and FEDER funds., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The helicase PIF1 facilitates resection over sequences prone to forming G4 structures

  • Jimeno, Sonia
  • Camarillo, Rosa
  • Mejías-Navarro, Fernando
  • Fernández-Ávila, María Jesús
  • Soria-Bretones, Isabel
  • Prados-Carvajal, Rosario
  • Huertas Sánchez, Pablo
DNA breaks are complex lesions that can be repaired either by non-homologous end joining (NHEJ) or by homologous recombination (HR). The decision between these two routes of DNA repair is a key point of the DNA damage response (DDR) that is controlled by DNA resection. The core machinery catalyzing the resection process is well established. However, little is known about the additional requirements of DNA resection over DNA structures with high complexity. Here, we found evidence that the human helicase PIF1 has a role in DNA resection, specifically for defined DNA regions, such as those prone to form G-quadruplexes. Indeed, PIF1 is recruited to the site of DNA damage and physically interacts with proteins involved in DNA resection, and its depletion causes DNA damage sensitivity and a reduction of HR efficiency. Moreover, G4 stabilization by itself hampers DNA resection, a phenomenon suppressed by PIF1 overexpression, This work was funded by an R+D+I grant from the Spanish Ministry of Economy and Competitivity (SAF2016-74855-P). F.M.-N. and R.P.-C. are funded with FPU fellowships from the Spanish Ministry of Education, and I.S.-B. was funded with a fellowship from the University of Sevilla (V Plan Propio). CABIMER is supported by the regional government of Andalucia (Junta de Andalucía)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

EXOSC10 is required for RPA assembly and controlled DNA end resection at DNA double-strand breaks

  • Domingo-Prim, Judit
  • Endara-Coll, Martin
  • Bonath, Franziska
  • Jimeno, Sonia
  • Prados-Carvajal, Rosario
  • Friedländer, Marc R.
  • Huertas Sánchez, Pablo
  • Visa, Neus
The exosome is a ribonucleolytic complex that plays important roles in RNA metabolism. Here we show that the exosome is necessary for the repair of DNA double-strand breaks (DSBs) in human cells and that RNA clearance is an essential step in homologous recombination. Transcription of DSB-flanking sequences results in the production of damage-induced long non-coding RNAs (dilncRNAs) that engage in DNA-RNA hybrid formation. Depletion of EXOSC10, an exosome catalytic subunit, leads to increased dilncRNA and DNA-RNA hybrid levels. Moreover, the targeting of the ssDNA-binding protein RPA to sites of DNA damage is impaired whereas DNA end resection is hyper-stimulated in EXOSC10-depleted cells. The DNA end resection deregulation is abolished by transcription inhibitors, and RNase H1 overexpression restores the RPA recruitment defect caused by EXOSC10 depletion, which suggests that RNA clearance of newly synthesized dilncRNAs is required for RPA recruitment, controlled DNA end resection and assembly of the homologous recombination machinery., This work was supported by grants from The Swedish Research Council (grants 2015-04553 to N.V. and 1403003 to M.F.), The Swedish Cancer Society (grant CAN 2016/460 to N.V.), and the Spanish Ministry of Economy and Competitivity (R + D + I project grant SAF2016-74855-P to P.H.). J.D.P. and M.E. were supported by the Department of Molecular Biosciences, the Wenner-Gren Institute at Stockholm University. J.D.P. and R.P.C. were recipients of short-term EMBO fellowships (STF-7513-2018 and STF-7764-2018). F.B. was supported by SFO funding from the Faculty of Science at the Stockholm University.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

UBQLN4 Represses Homologous Recombination and Is Overexpressed in Aggressive Tumors

  • Jachimowicz, Ron D.
  • Beleggia, Filippo
  • Isensee, Jörg
  • Velpula, Bhagya Bhavana
  • Goergens, Jonas
  • Bustos, Matias A.
  • Doll, Markus A.
  • Shenoy, Anjana
  • Checa-Rodríguez, Cintia
  • Wiederstein, Janica Lea
  • Baranes-Bachar, Keren
  • Bartenhagen, Christoph
  • Hertwig, Falk
  • Teper, Nizan
  • Nishi, Tomohiko
  • Schmitt, Anna
  • Distelmaier, Felix
  • Lüdecke, Hermann-Josef
  • Albrecht, Beate
  • Krüger, Markus
  • Schumacher, Björn
  • Geiger, Tamar
  • Hoon, Dave S.B.
  • Huertas Sánchez, Pablo
  • Fischer, Matthias
  • Hucho, Tim
  • Peifer, Martin
  • Ziv, Yael
  • Reinhardt, H. Christian
  • Wieczorek, Dagmar
  • Shiloh, Yosef
Genomic instability can be a hallmark of both human genetic disease and cancer. We identify a deleterious UBQLN4 mutation in families with an autosomal recessive syndrome reminiscent of genome instability disorders. UBQLN4 deficiency leads to increased sensitivity to genotoxic stress and delayed DNA double-strand break (DSB) repair. The proteasomal shuttle factor UBQLN4 is phosphorylated by ATM and interacts with ubiquitylated MRE11 to mediate early steps of homologous recombination-mediated DSB repair (HRR). Loss of UBQLN4 leads to chromatin retention of MRE11, promoting non-physiological HRR activity in vitro and in vivo. Conversely, UBQLN4 overexpression represses HRR and favors non-homologous end joining. Moreover, we find UBQLN4 overexpressed in aggressive tumors. In line with an HRR defect in these tumors, UBQLN4 overexpression is associated with PARP1 inhibitor sensitivity. UBQLN4 therefore curtails HRR activity through removal of MRE11 from damaged chromatin and thus offers a therapeutic window for PARP1 inhibitor treatment in UBQLN4-overexpressing tumors.Control of MRE11 association with chromatin by UBQLN4 during double-strand break repair influences repair pathway choice and can be dysregulated in tumorigenesis., This work was funded through the Dr. M. and S.G. Adelson Medical Research Foundation, The Israel Science Foundation joint ISF-NSFC Research Program and The Israel Cancer Research Fund (to Y.S.), the German-Israeli Foundation for Research and Development (I-65-412.20-2016 to Y.S. and H.C.R.), the Deutsche Forschungsgemeinschaft (KFO-286-RP2 to H.C.R., KFO-286-CP2 to M.P., JA2439/1-1 to R.D.J., DI1731/2-1 to F.D.), the Else Kröner-Fresenius Stiftung (2014-A06 to H.C.R., 2016_Kolleg.19 to R.D.J.), the Deutsche Krebshilfe (1117240 to H.C.R. and the Mildred-Scheel Professorship to M.P.), the German Ministry of Education and Research (BMBF 01GM1211B to D.W., BMBF e:Med 01ZX1303A and 01ZX1406 to M.P., BMBF e:Med 01ZX1303 and 01ZX1307 to M.F.), and R+D+I grants from the Spanish Ministry of Economy and Competitivity (SAF2013-43255-P and SAF2016-74855-P to P.H.). Y.S. is a Research Professor of the Israel Cancer Research Fund.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Preparation of a radiobiology beam line at the 18 MeV proton cyclotron facility at CNA

  • Baratto-Roldan, Anna
  • Jiménez-Ramos, M. C.
  • Jimeno, Sonia
  • Huertas Sánchez, Pablo
  • García López, J.
  • Gallardo, María Isabel
  • Cortés-Giraldo, Miguel Antonio
  • Espino, J. M.
Proton therapy has gained interest in recent years due to its excellent clinical outcomes. However, the lack of accurate biological data, especially in the Bragg peak region of clinical beams, makes it difficult to implement biophysically optimized treatment plans in clinical practice. In this context, low energy proton accelerator facilities provide the perfect environment to collect good radiobiological data, as they can produce high LET beams with narrow energy distributions. This study presents the radiobiology beam line that has been designed at the 18 MeV proton cyclotron facility at the National Centre of Accelerators (CNA, Seville, Spain), to perform irradiations of mono-layer cell cultures. To ensure that all the cells receive the same dose with a suitable dose rate, low beam intensities and broad and homogeneous beam profiles are necessary. To do so, at the CNA an unfocused beam has been used, broadened with a 500 μm thick aluminium scattering foil. Homogeneous dose profiles, with deviations lower than 10% have been obtained over a circular surface of 35 mm diameter for an incident average energy of 12.8 MeV. Further, a Monte Carlo simulation of the beam line has been developed with Geant4, and benchmarked towards experimental measurements, with differences generally below 1%. Once validated, the code has been used, together with an ionization chamber, for dosimetry studies, to characterize the beam and monitor the dose. Finally, cultures of Human Bone Osteosarcoma cells (U2OS) have been successfully irradiated at the radiobiology beam line, investigating the effects of radiation in terms of DNA damage induction., This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie Grant No. 675265, OMA–Optimization of Medical Accelerators; from the Spanish Plan for Scientific and Technical Research and Innovation under Grant No. FPA2016-77689-C2-1-R, Grant No. RTI2018-098117-B-C21 and Grant No. SAF2016-74855-P; and from the Council for Innovation, Science and Commerce of the Andalusian Government under Grant No. P12-FQM-1605. CABIMER is supported by the regional Government of Andalucia (Junta de Andalucía)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

ALC1/eIF4A1-mediated regulation of CtIP mRNA stability controls DNA end resection

  • Mejías-Navarro, Fernando
  • Rodríguez-Real, Guillermo
  • Ramón, Javier
  • Camarillo, Rosa
  • Huertas Sánchez, Pablo
During repair of DNA double-strand breaks, resection of DNA ends influences how these lesions will be repaired. If resection is activated, the break will be channeled through homologous recombination; if not, it will be simply ligated using the non-homologous end-joining machinery. Regulation of resection relies greatly on modulating CtIP, which can be done by modifying: i) its interaction partners, ii) its post-translational modifications, or iii) its cellular levels, by regulating transcription, splicing and/or protein stability/degradation. Here, we have analyzed the role of ALC1, a chromatin remodeler previously described as an integral part of the DNA damage response, in resection. Strikingly, we found that ALC1 affects resection independently of chromatin remodeling activity or its ability to bind damaged chromatin. In fact, it cooperates with the RNA-helicase eIF4A1 to help stabilize the most abundant splicing form of CtIP mRNA. This function relies on the presence of a specific RNA sequence in the 5′ UTR of CtIP. Therefore, we describe an additional layer of regulation of CtIP—at the level of mRNA stability through ALC1 and eIF4A1., This work was financed by an R+D+I grant from the Spanish Ministry of Economy and Competitivity (SAF2016-74855-P) and by the European Union Regional Funds (FEDER). FM-N was funded with an FPU fellowship from the Spanish Ministry of Education, and JR and GR-R were supported by the Regional Government of Andalucía (Junta de Andalucía) with a contract of the program “GARANTÍA JUVENIL EN LA UNIVERSIDAD DE SEVILLA”. CABIMER is supported by the regional government of Andalucía (Junta de Andalucía)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Methylation of the central transcriptional regulator KLF4 by PRMT5 is required for DNA end resection and recombination

  • Checa-Rodríguez, Cintia
  • Cepeda-García, Cristina
  • Ramón, Javier
  • López-Saavedra, Ana
  • Balestra, Fernando R.
  • Domínguez-Sánchez, María S.
  • Gómez-Cabello, Daniel
  • Huertas Sánchez, Pablo
Cell fitness and survival upon exposure to DNA damage depends on the repair of DNA lesions. Interestingly, cellular identity does affect and finetunes such response, although the molecular basis of such differences between tissues and cell types is not well understood. Thus, a possibility is that DNA repair itself is controlled by the mechanisms that govern cell identity. Here we show that the KLF4, involved in cellular homeostasis, proliferation, cell reprogramming and cancer development, directly regulates resection and homologous recombination proficiency. Indeed, resection efficiency follows KLF4 protein levels, i.e. decreases upon KLF4 downregulation and increases when is overexpressed. Moreover, KLF4 role in resection requires its methylation by the methyl-transferase PRMT5. Thus, PRMT5 depletion not only mimics KLF4 downregulation, but also showed an epistatic genetic relationship. Our data support a model in which the methylation of KLF4 by PRMT5 is a priming event required to license DNA resection and homologous recombination., This work was funded by R+D+I grants from the Spanish Ministry of Economy and Competitivity (SAF2013-43255-P, SAF2016-74855-P). FR-B is funded by the University of Sevillathrough a postdoctoral contract of the V PPIT-US. CABIMER is supported by the regional government of Andalucia (Junta de Andalucía)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Tesis doctoral (DoctoralThesis)

Crosstalk between DNA end resection and RNA metabolism

  • Prados-Carvajal, Rosario
Tesis llevada a cabo para conseguir el grado de Doctor por la Universidad de Sevilla.--2020-01-23, [EN] DNA suffers thousands of lesions from exogenous and endogenous sources. Nevertheless, double-strand breaks (DSBs) are the most dangerous form of DNA damage because if they are not properly repaired they can lead to mutations and genomic instability. In order to repair them, cells have developed two major pathways: Homologous Recombination and Non-Homologous End-Joining. CtIP is a key protein in this response since it promotes faithful repair of DSBs by licensing homologous recombination. Recently, a crosstalk between DNA Damage Response (DDR) and RNA metabolism at different levels has been discovered. Thus, in this Thesis we studied this relationship deeply. We described that the splicing complex SF3B is involved in in DNA damage repair. Although part of such function is through CtIP, we observed that SF3B plays additional roles in DNA double strand break repair that are independent of its functional relationship with this factor. Additionally, we demonstrated that this relationship is bidirectional, since CtIP is involved in DNA damage-dependent and independent alternative mRNA splicing of several genes. The careful study of the CtIPdependent splicing of one of those genes, the one that codes the helicase PIF1, suggest that those events are important for the fine tuning of the DNA damage response. Furthermore, we reported a crosstalk between the DDR and RNA editing. RNA editing is, indeed, upregulated upon exposure to DNA damage in a fashion that requires CtIP and the checkpoint kinase ATR. Moreover, our data agree with the idea that the RNA editing enzymes ADARs have a role in the removal of DNA:RNA hybrids that facilitates DSB repair., [ES] El ADN sufre muchísimos tipos de daño debido a fuentes externas o internas. No obstante, los cortes de doble cadena son de los más peligrosos porque si no se reparan adecuadamente, pueden conducir a mutaciones e inestabilidad genómica. Para reparar este daño, las células han desarrollado principalmente dos vías: la recombinación homóloga o la unión de extremos no homólogos. CtIP es una proteína clave en esta respuesta al daño porque activa la reparación de los cortes de doble cadena vía recombinación homóloga. Recientemente se ha descrito una conexión a diferentes niveles entre la respuesta al daño en el ADN (DDR por sus siglas en inglés) y el metabolismo del ARN. Por eso, en esta Tesis hemos estudiado dicha relación en profundidad. Descubrimos que el complejo de procesamiento de intrones denominado SF3B está involucrado en la reparación del daño del ADN. Aunque parte de las funciones que realiza en este proceso son a través de CtIP, también hemos demostrado que SF3B tiene otro papel independiente de su relacional funcional con esta proteína. Además, hemos comprobamos que esta relación es bidireccional, ya que CtIP también esta involucrado en el procesamiento alternativo de intrones de numerosos genes, tanto de manera constitutiva como en respuesta a la presencia de daño en el ADN. El estudio cuidadoso del la maduración de intrones dependiente de CtIP de uno de esos genes, el que codifica la helicasa PIF1, sugiere que estos eventos permiten el ajuste fino de la respuesta al daño en el ADN. Asimismo, pudimos observar una interrelación entre la DRR y el proceso de edición del ARN. La edición del ARN, de hecho, aumenta como respuesta a la presencia de daño en el ADN en un proceso regulado por CtIP y la quinasa ATR. Además, nuestros datos están de acuerdo con la idea de que las proteínas de edición de ARN ADARs juegan un papel en la disolución de híbridos de ADN:ARN que facilita la reparación de cortes de doble cadena en el ADN., I did this work thanks to receiving a FPU fellowship from the Spanish Ministry of Education (FPU. Additionally, these projects were funded by two R+D+I grants from the Spanish Ministry of Economy and Competitivity (SAF2013-43255-P and SAF2016- 74855-P) and a Starting Grant from the European Research Council (DSBRECA).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

MRGBP, a member of the NuA4 complex, inhibits DNA double-strand break repair

  • Rivero, Sabrina
  • Rodríguez-Real, Guillermo
  • Marín, Inés
  • Huertas Sánchez, Pablo
The repair of DNA breaks takes place in the context of chromatin and thus involves the activity of chromatin remodelers. The nucleosome acetyltransferase of H4 (NuA4) remodeler complex enables DNA break repair by relaxing flanking chromatin. Here, we show that MRG domain binding protein (MRGBP), a member of this complex, acts as a general inhibitor of DNA double-strand break repair. Upon its downregulation, repair is generally increased. This is particularly evident for the stimulation of early events of homologous recombination. Thus, MRGBP has an opposing role to the main catalytic subunits of the NuA4 complex. Our data suggest that MRGBP acts by limiting the activity of this complex in DNA repair, specifically by narrowing the extent of DNA-end resection., This work was funded by a R+D+I grant from the Spanish Ministry of Economy and Competitivity (SAF2016-74855-P) and by the European Union Regional Funds (FEDER). GR-L was supported by the Regional Government of Andalucía (Junta de Andalucía) with a contract of the program ‘GARANTÍA JUVENIL EN LA UNIVERSIDAD DE SEVILLA’. CABIMER is supported by the regional government of Andalucía (Junta de Andalucía).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

ADAR-mediated RNA editing of DNA:RNA hybrids is required for DNA double strand break repair

  • Jimeno, Sonia
  • Prados-Carvajal, Rosario
  • Fernández-Ávila, María Jesús
  • Silva, Sonia
  • Silvestris, Domenico Alessandro
  • Endara-Coll, Martin
  • Rodríguez-Real, Guillermo
  • Domingo-Prim, Judit
  • Mejías-Navarro, Fernando
  • Romero-Franco, Amador
  • Jimeno-González, Silvia
  • Barroso, Sonia
  • Cesarini, Valeriana
  • Aguilera, Andrés
  • Gallo, Ángela
  • Visa, Neus
  • Huertas Sánchez, Pablo
The maintenance of genomic stability requires the coordination of multiple cellular tasks upon the appearance of DNA lesions. RNA editing, the post-transcriptional sequence alteration of RNA, has a profound effect on cell homeostasis, but its implication in the response to DNA damage was not previously explored. Here we show that, in response to DNA breaks, an overall change of the Adenosine-to-Inosine RNA editing is observed, a phenomenon we call the RNA Editing DAmage Response (REDAR). REDAR relies on the checkpoint kinase ATR and the recombination factor CtIP. Moreover, depletion of the RNA editing enzyme ADAR2 renders cells hypersensitive to genotoxic agents, increases genomic instability and hampers homologous recombination by impairing DNA resection. Such a role of ADAR2 in DNA repair goes beyond the recoding of specific transcripts, but depends on ADAR2 editing DNA:RNA hybrids to ease their dissolution., This work was funded by an R + D + I grant from the Agencia Estatal de Investigación PID2019-104195GB-I00/ AEI/10.13039/501100011033 (P.H.), R + D + I grants from the Spanish Ministry of Economy and Competitiveness (SAF2016-74855-P to P.H. and BFU2016-75058-P to A.A.), the European Research Council (ERC2014 AdG669898 TARLOOP to A.A.), the Associazione Italiana Ricerca sul Cancro-AIRC (AIRC IG 22080 to A.G.), The Swedish Research Council (grants 2015-04553 to N.V.), The Swedish Cancer Society (grant CAN 2016/460 to N.V.) and the European Union (FEDER). AR is, and FM-N and RP-C were, funded with FPU fellowships from the Spanish Ministry of Education and S.S. by a Juan de la Cierva contract from the Spanish Ministry of Economy and Competitiveness. J.D.P. and M.E-C. were supported by the Department of Molecular Biosciences, The Wenner-Gren Institute at Stockholm University. J.D-P. and R.P-C. were recipients of short-term EMBO fellowships (STF- 7513-2018 and STF-7764-2018). The mutational results shown here are in whole or part based upon the data generated by the TCGA Research Network: https://www.cancer.gov/tcga. All the bioinformatic analyses were performed using custom scripts that were run on the High performance computing cluster provided by the Centro Informático Cienti ́fico de Andalucía (CICA). CABIMER is supported by the regional government of Andalucia (Junta de Andalucía).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

DNA topoisomerase IIß inhibition blocks DNA end resection and synergizes with PARPi in BRCA1-deficient models

  • Camarillo, Rosa
  • Prados-Carvajal, Rosario
  • Cruz-García, Andrés
  • Rodríguez-Real, Guillermo
  • Herencia-Ropero, Andrea
  • Serra, Violeta
  • Jimeno, Sonia
  • Huertas Sánchez, Pablo
DNA end resection is a critical step that governs how a broken chromosome will be repaired. As such, it is heavily regulated by multiple cellular signals and processes. Alterations in the regulation of DNA end resection have consequences for cell survival upon exposure to cytotoxic agents, including those used during cancer chemotherapy. Here, we identified several small molecules that affect the process of DNA end resection. Among them, we focus on determining the mode of action of merbarone, a DNA topoisomerase II inhibitor. We uncover a role of the topoisomerase IIβ isoform in the full processing of DNA breaks. Moreover, we show that the effect of merbarone is affected by the formation of G4 quadruplexes and that BRCA1-deficient cancer cells are sensitive to merbarone. Strikingly, this sensitivity can be partially suppressed in cell lines expressing hypomorphic versions of BRCA1 lacking exon 11, a hypomorph that has been linked to PARPi-resistance. Using cellular models, we show that PARPi- and merbarone-resistant BRCA1 exon 11 mutant cells, but not wildtype BRCA1 cells, are sensitive to the combination of both drugs. Finally, we show that combination of merbarone and the PARPi olaparib has a mild antitumor effect in a PARPi-resistant PDX model bearing a BRCA1 exon 11 mutation., This work was funded by the R+D+I grants SAF2013-43255-P, SAF2016-74855-P, PID2019-104195G and PID2022-136791NB-I00 funded by MICIU/AEI/10.13039/501100011033/ FEDER/UE to P.H., and grants PID2022-140603NB-I00 funded by MICIU/AEI/10.13039/501100011033/ FEDER/UE and the Ideas Semilla Project IDEAS222767JIME from the Asociación Española Contra el Cáncer (AECC) to S.J and the SINERGIA project SNRGS247052PRAD from AECC to RP-C. RC-D was funded with an FPI fellowship from the Spanish Ministry of Economy and Competitivity. RP-C was funded with an FPU fellowship from the Spanish Ministry of Education and a Postdoctoral Fellowship from the Asociación Española Contra el Cáncer (AECC). AC-G was supported by the Government of Mexico with a fellowship of the CONACYT. CABIMER is supported by the Regional Government of Andalucía (Junta de Andalucía). V.S. received funds from the Instituto de Salud Carlos III (ISCIII), an initiative of the Spanish Ministry of Economy and Innovation partially supported by European Regional Development FEDER Funds (PI20/00892 and CPII19/00033). AH-R received funding from Generalitat de Catalunya (PERIS SLT017/20/000081). P. Huertas and R. Prados-Carvajal disclose non-financial support from AstraZeneca. Additionally, V. Serra reports research grants from AstraZeneca and personal fees and/or nonfinancial support from AstraZeneca and GSK., Peer reviewed